ERBB2 and neoplasm: In contrast to biomarkers that are constitutively overexpressed due to genomic aberrations, such as HER2/neu, ER and PR expression reflects residual differentiation of tumor cells still sharing commonalities with a potential corresponding "cell of origin" in the normal breast epithelium [8].